What MediWound Ltd.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 7 |
| Sells | 4 | 4 |
| Total trades | 5 | 11 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 11 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rubinstein Samuel | Director | Sep 01 | Open-market buy · P | +525 | $12.62 | +$6.63K | 525 |
| Rubinstein Samuel | Director | Sep 01 | Open-market sale · S | −525 | $12.72 | −$6.68K | 0 |
| Hess Shmuel | COO & Chief Commercial Officer | Aug 27 | Open-market sale · S | −1,979 | $13.13 | −$26K | 0 |
| Hess Shmuel | COO & Chief Commercial Officer | Aug 27 | Open-market sale · S | −1,979 | $12.72 | −$25.2K | 0 |
| Hess Shmuel | COO & Chief Commercial Officer | Aug 26 | Open-market sale · S | −1,865 | $13.00 | −$24.2K | 0 |
| Shamir Nachum | Director | Jun 03 | Open-market buy · P | +5,825 | $14.00 | +$81.6K | 55,815 |
| Shamir Nachum | Director | Jun 03 | Open-market buy · P | +175 | $13.98 | +$2.45K | 49,990 |
| Fox David Morton | Director | Jun 01 | Open-market buy · P | +1,797 | $14.00 | +$25.1K | 22,283 |
| Fox David Morton | Director | Jun 01 | Open-market buy · P | +10 | $14.23 | +$142 | 20,486 |
| Fox David Morton | Director | Jun 01 | Open-market buy · P | +1,730 | $14.23 | +$24.6K | 20,476 |
| Rubinstein Samuel | Director | May 29 | Open-market buy · P | +150 | $14.33 | +$2.15K | 2,993 |
Loading...